Deficiency of immunophilin FKBP52 promotes endometriosis

American Journal of Pathology

Volumn 173, Issue 6, 2008, Pages 1747-1757

  Hirota, Yasushi ^a,c   Tranguch, Susanne ^a   Daikoku, Takiko ^a   Hasegawa, Akiko ^c   Osuga, Yutaka ^c   Taketani, Yuji ^c   Dey, Sudhansu K ^a,b,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; FK 506 BINDING PROTEIN 4; IMMUNOPHILIN; PROGESTERONE; PROTEIN FKBP52; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIOSIS; ESTROGEN ACTIVITY; FEMALE; FKBP52 GENE; GENE; GENE DELETION; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRANSCRIPTION REGULATION;

EID: 57149113152     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080527     Document Type: Article

References (73)

1. Maruyama M, Osuga Y, Momoeda M, Yano T, Tsutsumi O, Taketani Y: Pregnancy rates after laparoscopic treatment. Differences related to tubal status and presence of endometriosis. J Reprod Med 2000, 45:89-93
2. Momoeda M, Taketani Y, Terakawa N, Hoshiai H, Tanaka K, Tsutsumi O, Osuga Y, Maruyama M, Harada T, Obata K, Hayashi K: Is endometriosis really associated with pain? Gynecol Obstet Invest 2002, 54 Suppl 1:18-21; discussion 21-13
3. Giudice LC, Kao LC: Endometriosis. Lancet 2004, 364:1789-1799
4. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the pelvic cavity. Am J Obstet Gynecol 1927, 14:422-469
5. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H: Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002, 83:149-155
6. Lessey BA: Medical management of endometriosis and infertility. Fertil Steril 2000, 73:1089-1096
7. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Jr., Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278
8. Fang Z, Yang S, Lydon JP, DeMayo F, Tamura M, Gurates B, Bulun SE: Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis. Fertil Steril 2004, 82:673-678
9. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG: Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002, 87:4782-4791
10. Minici F, Tiberi F, Tropea A, Orlando M, Gangale MF, Romani F, Campo S, Bompiani A, Lanzone A, Apa R: Endometriosis and human infertility: a new investigation into the role of eutopic endometrium. Hum Reprod 2008, 23:530-537
11. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE: Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000, 85:2897-2902
12. Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, Attar E, Innes J, Julie Kim J: Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 2006, 248:94-103
13. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC: Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144:2870-2881
14. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC: Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007, 148:3814-3826
15. Barent RL, Nair SC, Carr DC, Ruan Y, Rimerman RA, Fulton J, Zhang Y, Smith DF: Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol 1998, 12:342-354
16. Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, Wang H, Das SK, Smith DF, Dey SK: Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 2005, 102:14326-14331
17. Tranguch S, Wang H, Daikoku T, Xie H, Smith DF, Dey SK: FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J Clin Invest 2007, 117:1824-1834
18. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF: Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 2005, 19:1654-1666
19. Wang H, Xie H, Sun X, Tranguch S, Zhang H, Jia X, Wang D, Das SK, Desvergne B, Wahli W, DuBois RN, Dey SK: Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success. J Biol Chem 2007, 282:37770-37782
20. Hirata T, Osuga Y, Yoshino O, Hirota Y, Harada M, Takemura Y, Morimoto C, Koga K, Yano T, Tsutsumi O, Taketani Y: Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. Hum Reprod 2005, 20:2092-2096
21. Yoshino O, Osuga Y, Koga K, Hirota Y, Hirata T, Ruimeng X, Na L, Yano T, Tsutsumi O, Taketani Y: FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J Reprod Immunol 2006, 72:85-93
22. Cornillie FJ, Oosterlynck D, Lauweryns JM, Koninckx PR: Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil Steril 1990, 53:978-983
23. Noyes RW, Hertig AI, Rock J: Dating the endometrial biopsy. Fertil Steril 1950, 1:3-25
24. Daikoku T, Tranguch S, Friedman DB, Das SK, Smith DF, Dey SK: Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus. Mol Endocrinol 2005, 19:683-697
25. Nisolle M, Casanas-Roux F, Donnez J: Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 1997, 68:912-919
26. Beliard A, Noel A, Foidart JM: Reduction of apoptosis and proliferation in endometriosis. Fertil Steril 2004, 82:80-85
27. Sales KJ, Jabbour HN: Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003, 126:559-567
28. McLaren J: Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000, 6:45-55
29. McCarty KS, Jr., Miller LS, Cox EB, Konrath J, McCarty KS, Sr: Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985, 109:716-721
30. Ma W, Tan J, Matsumoto H, Robert B, Abrahamson DR, Das SK, Dey SK: Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 2001, 15:1983-1992
31. Matsumoto H, Ma WG, Daikoku T, Zhao X, Paria BC, Das SK, Trzaskos JM, Dey SK: Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J Biol Chem 2002, 277:29260-29267
32. Gazvani R, Templeton A: Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002, 123:217-226
33. Oral E, Olive DL, Arici A: The peritoneal environment in endometriosis. Hum Reprod Update 1996, 2:385-398
34. Akoum A, Jolicoeur C, Boucher A: Estradiol amplifies interleukin-1- induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab 2000, 85:896-904
35. Akoum A, Lemay A, Maheux R: Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells. J Clin Endocrinol Metab 2002, 87:5785-5792
36. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN: Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996, 81:3112-3118
37. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996, 98:482-489
38. Hirota Y, Osuga Y, Koga K, Yoshino O, Hirata T, Morimoto C, Harada M, Takemura Y, Nose E, Yano T, Tsutsumi O, Taketani Y: The expression and possible roles of chemokine CXCL11 and its receptor CXCR3 in the human endometrium. J Immunol 2006, 177:8813-8821
39. Brosens IA: Endometriosis - a disease because it is characterized by bleeding. Am J Obstet Gynecol 1997, 176:263-267
40. Scotti S, Regidor PA, Schindler AE, Winterhager E: Reduced proliferation and cell adhesion in endometriosis. Mol Hum Reprod 2000, 6:610-617
41. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Ishimaru T: Higher activity by opaque endometriotic lesions than nonopaque lesions. Acta Obstet Gynecol Scand 2004, 83:375-382
42. Ota H, Igarashi S, Sasaki M, Tanaka T: Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001, 16:561-566
43. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998, 13:1686-1690
44. Hull ML, Prentice A, Wang DY, Butt RP, Phillips SC, Smith SK, Charnock-Jones DS: Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod 2005, 20:350-358
45. Lu XE, Ning WX, Dong MY, Liu AX, Jin F, Huang HF: Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse mode. Fertil Steril 2006, 86 Suppl 4:1175-1181
46. Becker CM, D'Amato RJ: Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 2007, 74:121-130
47. Taylor RN, Lebovic DI, Mueller MD: Angiogenic factors in endometriosis. Ann NY Acad Sci 2002, 955:89-100; discussion 118, 396-406
48. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66
49. Nisolle M, Donnez J: Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997, 68:585-596
50. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM: Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000, 289:1751-1754
51. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM: Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 2003, 100:9744-9749
52. Mote PA, Balleine RL, McGowan EM, Clarke CL: Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1999, 84:2963-2971
53. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF: The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J 2003, 22:1158-1167
54. Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS: Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther 1999, 289:1202-1210
55. Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S, Srivastava A: Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 2001, 75:8968-8976
56. Slayden OD, Brenner RM: RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 1994, 78:440-448
57. Kayisli UA, Luk J, Guzeloglu-Kayisli O, Seval Y, Demir R, Arici A: Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab 2004, 89:5794-5802
58. Bredhult C, Backlin BM, Olovsson M: Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod Toxicol 2007, 23:550-559
59. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25
60. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN: Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA 2000, 97:10972-10977
61. Akoum A, Lemay A, McColl S, Turcot-Lemay L, Maheux R: Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1996, 66:17-23
62. Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV: Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993, 169:1545-1549
63. Hirota Y, Osuga Y, Hirata T, Yoshino O, Koga K, Harada M, Morimoto C, Nose E, Yano T, Tsutsumi O, Taketani Y: Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2005, 90:3673-3679
64. Ceyhan ST, Onguru O, Baser I, Gunhan O: Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertil Steril 2007
65. Laschke MW, Elitzsch A, Scheuer C, Vollmar B, Menger MD: Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 2007, 87:163-171
66. Ward BK, Mark PJ, Ingram DM, Minchin RF, Ratajczak T: Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res Treat 1999, 58:267-280
67. Periyasamy S, Warrier M, Tillekeratne MP, Shou W, Sanchez ER: The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Endocrinology 2007, 148:4716-4726
68. Lin JF, Xu J, Tian HY, Gao X, Chen QX, Gu Q, Xu GJ, Song JD, Zhao FK: Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer 2007, 121:2596-2605
69. Ning YM, Sanchez ER: Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J Biol Chem 1993, 268:6073-6076
70. Tai PK, Albers MW, McDonnell DP, Chang H, Schreiber SL, Faber LE: Potentiation of progesterone receptor-mediated transcription by the immunosuppressant FK506. Biochemistry 1994, 33:10666-10671
71. Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, Takemura Y, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Saito S, Yano T, Taketani Y: Interleukin (IL)-17A stimulates IL-8 secretion. Cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 2008, 149:1260-1267
72. OuYang Z, Hirota Y, Osuga Y, Hamasaki K, Hasegawa A, Tajima T, Hirata T, Koga K, Yoshino O, Harada M, Takemura Y, Nose E, Yano T, Taketani Y: Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 2008, 173:463-469
73. Jackson KS, Brudney A, Hastings JM, Mavrogianis PA, Kim JJ, Fazleabas AT: The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity. Reprod Sci 2007, 14:137-150